Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal CarcinomaYuan Zhang, Jun Ma, Lei Chen et al.|New England Journal of Medicine|2019Cited by 934
Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO GuidelineYu‐Pei Chen, Nofisat Ismaila, Melvin L.K. Chua et al.|Journal of Clinical Oncology|2021Cited by 393
Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensusGiuseppe Curigliano, Uwe G. Liebert, Solange Peters et al.|Annals of Oncology|2020Cited by 313
Liquid biopsy tracking during sequential chemo-radiotherapy identifies distinct prognostic phenotypes in nasopharyngeal carcinomaJia‐Wei Lv, Ying Sun, Yu‐Pei Chen et al.|Nature Communications|2019Cited by 163
Embracing Personalized Strategies in Radiotherapy for Nasopharyngeal Carcinoma: Beyond the Conventional Bounds of Fields and BordersPui Lam Yip, Melvin L.K. Chua|Cancers|2024Cited by 17